EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitLeitlinie

Chapter 6: Syndromic primary hyperparathyroidism

Abdallah Al-Salameh, Magalie Haissaguerre, Christophe Tresallet, Paulina Kuczma, Camille Marciniak, Catherine Cardot-Bauters

Annales d'Endocrinologie · 2025

DOI: 10.1016/j.ando.2025.101695 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Annales d'Endocrinologie, 2025. Verfasst von Abdallah Al-Salameh und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Diabetes and Nutrition, Amiens University Hospital, Amiens, France. Hauptthemen laut MEDLINE: Hyperparathyroidism, Primary. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 60 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Syndromic primary hyperparathyroidism has several features in common: younger age at diagnosis when compared with sporadic primary hyperparathyroidism, often synchronous or metachronous multi-glandular involvement, higher possibility of recurrence, association with other endocrine or extra-endocrine disorders, and suggestive family background with autosomal dominant inheritance. Hyperparathyroidism in multiple endocrine neoplasia type 1 is the most common syndromic hyperparathyroidism. It is often asymptomatic in adolescents and young adults, but may be responsible for recurrent lithiasis and/or bone loss. Hyperparathyroidism-jaw tumor syndrome is less frequent, but often immediately symptomatic, with higher blood calcium levels, and is sometimes associated with an atypic parathyroid tumor or parathyroid carcinoma. Hyperparathyroidism in multiple endocrine neoplasia type 2A is not at the forefront of the clinical picture, rarely revealing the disease, and often manifests with few symptoms. Multiple endocrine neoplasia type 4 is a more recently described entity, in which hyperparathyroidism seems to occur later and be less severe than in previous syndromes. In all cases, the indications and modalities of surgical treatment should be discussed in an expert center. The risk of recurrence after surgery, particularly high in multiple endocrine neoplasia type 1, requires long-term monitoring.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hyperparathyroidism, PrimaryHumansSyndromeParathyroid NeoplasmsMultiple Endocrine Neoplasia Type 1AdolescentAdult

Stichwörter der Autor:innen

GeneticsHPT-JTHyperparathyroidismMEN1MEN2MEN4

Autor:innen und Institutionen

  • Department of Endocrinology, Diabetes and Nutrition, Amiens University Hospital, Amiens, France.
  • Service d'endocrinologie et oncologie endocrinienne, hôpital Haut Lévêque, CHU de Bordeaux, Pessac, France.
  • Service de chirurgie digestive, bariatrique et endocrinienne, université Sorbonne Paris Nord, CHU d'Avicenne, Assistance publique-Hôpitaux de Paris, Bobigny, France.
  • General and Endocrine Surgery Department, Huriez Hospital, Lille University Hospital, Lille, France.
  • Endocrinology Department, Huriez Hospital, Lille University Hospital, Lille, France. Electronic address: catherine.cardot@chu-lille.fr.

Zitieren

APA

Al-Salameh, A., Haissaguerre, M., Tresallet, C., Kuczma, P., Marciniak, C., & Cardot-Bauters, C. (2025). Chapter 6: Syndromic primary hyperparathyroidism. Annales d'Endocrinologie. https://doi.org/10.1016/j.ando.2025.101695

Vancouver

Al-Salameh A, Haissaguerre M, Tresallet C, Kuczma P, Marciniak C, Cardot-Bauters C. Chapter 6: Syndromic primary hyperparathyroidism. Annales d'Endocrinologie. 2025. doi:10.1016/j.ando.2025.101695

BibTeX
@article{AlSalameh2025,
  author = {Al-Salameh, Abdallah and Haissaguerre, Magalie and Tresallet, Christophe and Kuczma, Paulina and Marciniak, Camille and Cardot-Bauters, Catherine},
  title = {Chapter 6: Syndromic primary hyperparathyroidism},
  journal = {Annales d'Endocrinologie},
  year = {2025},
  doi = {10.1016/j.ando.2025.101695}
}
Kostenlos starten →